Polyshield-B 5LU Injection
Prescription Required

Product introduction
Polyshield-B 5LU Injection is given under the supervision of a healthcare professional. You should get the injections at the same time each day to get the most benefit and you should keep on taking this medicine for as long as you are prescribed it, even if your symptoms quickly improve. If you stop taking it too early the infection may return or worsen.
Some people may develop side effects like anaphylactic reaction, kidney damage, neurotoxicity, fever, or pain, redness, and swelling at the site of injection. These side effects are usually temporary and go away during treatment as your body adjusts to the medicine. Consult your doctor if these side effects bother you or will not go away.
Before starting treatment with this medicine, you should tell your doctor if you are allergic to any antibiotic or have any liver or kidney problems. Pregnant women should consult their doctor before using it. Your doctor may get regular blood tests done to monitor kidney function.
Uses of Polyshield-B Injection
- Treatment of Severe bacterial infections
Benefits of Polyshield-B Injection
In Treatment of Severe bacterial infections
This medicine usually makes you feel better very quickly but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
Side effects of Polyshield-B Injection
Common side effects of Polyshield-B
- Anaphylactic reaction
- Fever
- Kidney damage
- Neurotoxicity
- Injection site reactions (pain, swelling, redness)
How to use Polyshield-B Injection
How Polyshield-B Injection works
Safety advice
What if you forget to take Polyshield-B Injection?
All substitutes
Quick tips
- Polyshield-B 5LU Injection treats serious bacterial infections that have not responded to treatment with other antibiotics.
- It is given by injection or drip (infusion) into a vein usually over 30-60 minutes.
- Finish the prescribed course, even if you start to feel better. Stopping it early may make the infection come back and harder to treat.
- Diarrhea may occur as a side effect. Inform your doctor if it doesn't stop or if you find blood in your stools.
- Your doctor may get regular blood tests done to monitor the level of the medicine in your blood.
- Polyshield-B 5LU Injection treats serious bacterial infections that have not responded to treatment with other antibiotics.
- It is given by injection or drip (infusion) into a vein usually over 30-60 minutes.
- Finish the prescribed course, even if you start to feel better. Stopping it early may make the infection come back and harder to treat.
- Your doctor may get regular blood tests done to monitor the level of the medicine in your blood.
Fact Box
Interaction with drugs
FAQs
What is Polyshield-B 5LU Injection? What is it used for?
How is Polyshield-B 5LU Injection administered?
Is Polyshield-B 5LU Injection safe?
What are the side effects of Polyshield-B 5LU Injection?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- MacDougall C, Chambers HF. Protein Synthesis Inhibitors and Miscellaneous Antibacterial Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1538-39.
- Chambers HF, Deck DH. Miscellaneous Antimicrobial Agents; Disingectants, Antiseptics, & Sterilants. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 878.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1133.






